Efficacy of folic acid supplementation in cardiovascular disease prevention: An updated meta-analysis of randomized controlled trials

European Journal of Internal Medicine

Volumn 23, Issue 8, 2012, Pages 745-754

  Yang, Hsin Ta ^a   Lee, Meng ^a   Hong, Keun Sik ^b   Ovbiagele, Bruce ^c   Saver, Jeffrey L ^d  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b Inje University College of Medicine   (South Korea)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cardiovascular disease; Coronary heart disease; Folic acid; Meta analysis; Randomized controlled trial; Stroke

Indexed keywords

FOLIC ACID;

ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; ISCHEMIC HEART DISEASE; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; VITAMIN SUPPLEMENTATION;

ADULT; AGED; ANGINA, UNSTABLE; CARDIOVASCULAR DISEASES; CORONARY DISEASE; FEMALE; FOLIC ACID; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; RISK FACTORS; STROKE; VITAMIN B COMPLEX;

EID: 84869081039     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2012.07.004     Document Type: Article

References (56)

1. K.S. McCully Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis Am J Pathol 56 1969 111 128
2. M. Curro, S. Condello, D. Caccamo, N. Ferlazzo, G. Parisi, and R. Ientile Homocysteine-induced toxicity increases TG2 expression in Neuro2a cells Amino Acids 36 2009 725 730
3. G.N. Welch, and J. Loscalzo Homocysteine and atherothrombosis N Engl J Med 338 1998 1042 1050 (Pubitemid 128753793)
4. P.M. Ridker, J.E. Manson, J.E. Buring, J. Shih, M. Matias, and C.H. Hennekens Homocysteine and risk of cardiovascular disease among postmenopausal women JAMA 281 1999 1817 1821 (Pubitemid 29231132)
5. H. Iso, Y. Moriyama, S. Sato, A. Kitamura, T. Tanigawa, and K. Yamagishi Serum total homocysteine concentrations and risk of stroke and its subtypes in Japanese Circulation 109 2004 2766 2772 (Pubitemid 38737924)
6. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis JAMA 288 2002 2015 2022
7. R.A. Jacob, M.M. Wu, S.M. Henning, and M.E. Swendseid Homocysteine increases as folate decreases in plasma of healthy men during short-term dietary folate and methyl group restriction J Nutr 124 1994 1072 1080 (Pubitemid 24226512)
8. D.E. Wilcken, and B. Wilcken The natural history of vascular disease in homocystinuria and the effects of treatment J Inherit Metab Dis 20 1997 295 300 (Pubitemid 27273492)
9. E.G. Vermeulen, C.D. Stehouwer, J.W. Twisk, M. van den Berg, S.C. de Jong, and A.J. Mackaay Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial Lancet 355 2000 517 522 (Pubitemid 30088670)
10. H.N. Hodis, W.J. Mack, L. Dustin, P.R. Mahrer, S.P. Azen, and R. Detrano High-dose B vitamin supplementation and progression of subclinical atherosclerosis: a randomized controlled trial Stroke 40 2009 730 736
11. E. Lonn, S. Yusuf, M.J. Arnold, P. Sheridan, J. Pogue, and M. Micks Homocysteine lowering with folic acid and B vitamins in vascular disease N Engl J Med 354 2006 1567 1577
12. J.F. Toole, M.R. Malinow, L.E. Chambless, J.D. Spence, L.C. Pettigrew, and V.J. Howard Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial JAMA 291 2004 565 575 (Pubitemid 38500310)
13. CM, N.R. Cook, J.M. Gaziano, E. Zaharris, J. MacFadyen, and E. Danielson Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial JAMA 299 2008 2027 2036 (Pubitemid 351656584)
14. A.J. Marti-Carvajal, I. Sola, D. Lathyris, and G. Salanti Homocysteine lowering interventions for preventing cardiovascular events Cochrane Database Syst Rev 2009 CD006612
15. J. Higgins, and S. Green Cochrane handbook for systematic reviews of interventions 2008 Cochrane Collaboration and John Wiley & Sons Ltd.
16. D. Moher, D.J. Cook, S. Eastwood, I. Olkin, D. Rennie, and D.F. Stroup Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses Lancet 354 1999 1896 1900
17. J.P. Higgins, and S.G. Thompson Quantifying heterogeneity in a meta-analysis Stat Med 21 2002 1539 1558 (Pubitemid 34746062)
18. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560 (Pubitemid 37088507)
19. S. Greenland, and J.M. Robins Estimation of a common effect parameter from sparse follow-up data Biometrics 41 1985 55 68
20. N. Mantel, and W. Haenszel Statistical aspects of the analysis of data from retrospective studies of disease J Natl Cancer Inst 22 1959 719 748
21. J.A. Sterne, and M. Egger Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis J Clin Epidemiol 54 2001 1046 1055 (Pubitemid 32888370)
22. A. Liem, G.H. Reynierse-Buitenwerf, A.H. Zwinderman, J.W. Jukema, and D.J. van Veldhuisen Secondary prevention with folic acid: effects on clinical outcomes J Am Coll Cardiol 41 2003 2105 2113 (Pubitemid 36724253)
23. P.W. Nanayakkara, J.C. Kiefte-de Jong, P.M. ter Wee, C.D. Stehouwer, F.J. van Ittersum, and M.R. Olthof Randomized placebo-controlled trial assessing a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on plasma asymmetric dimethylarginine concentration in mild to moderate CKD Am J Kidney Dis 53 2009 41 50
24. D.J. Rakhit, T.H. Marwick, K.A. Armstrong, D.W. Johnson, R. Leano, and N.M. Isbel Effect of aggressive risk factor modification on cardiac events and myocardial ischaemia in patients with chronic kidney disease Heart 92 2006 1402 1408 (Pubitemid 44578827)
25. S.D. Mark, W. Wang, J.F. Fraumeni Jr., J.Y. Li, P.R. Taylor, and G.Q. Wang Lowered risks of hypertension and cerebrovascular disease after vitamin/mineral supplementation: the Linxian Nutrition Intervention Trial Am J Epidemiol 143 1996 658 664 (Pubitemid 26111079)
26. G. Schnyder, M. Roffi, Y. Flammer, R. Pin, and O.M. Hess Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial JAMA 288 2002 973 979 (Pubitemid 34920462)
27. M. Righetti, G.M. Ferrario, S. Milani, P. Serbelloni, L. La Rosa, and M. Uccellini Effects of folic acid treatment on homocysteine levels and vascular disease in hemodialysis patients Med Sci Monit 9 2003 PI37 PI142
28. M. Righetti, P. Serbelloni, S. Milani, and G. Ferrario Homocysteine-lowering vitamin B treatment decreases cardiovascular events in hemodialysis patients Blood Purif 24 2006 379 386 (Pubitemid 44215183)
29. H. Lange, H. Suryapranata, G. De Luca, C. Borner, J. Dille, and K Kallmayer Folate therapy and in-stent restenosis after coronary stenting N Engl J Med 350 2004 2673 2681 (Pubitemid 38788002)
30. A.H. Liem, A.J. van Boven, N.J. Veeger, A.J. Withagen, and R.M. Robles de Medina Efficacy of folic acid when added to statin therapy in patients with hypercholesterolemia following acute myocardial infarction: a randomised pilot trial Int J Cardiol 93 2004 175 179 (Pubitemid 38229585)
31. A. Liem, G.H. Reynierse-Buitenwerf, A.H. Zwinderman, J.W. Jukema, and D.J. van Veldhuisen Secondary prevention with folic acid: results of the Goes extension study Heart 91 2005 1213 1214 (Pubitemid 41192405)
32. E.M. Wrone, J.M. Hornberger, J.L. Zehnder, L.M. McCann, N.S. Coplon, and S.P. Fortmann Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease J Am Soc Nephrol 15 2004 420 426 (Pubitemid 38140783)
33. K.H. Bonaa, I. Njolstad, P.M. Ueland, H. Schirmer, A. Tverdal, and T. Steigen Homocysteine lowering and cardiovascular events after acute myocardial infarction N Engl J Med 354 2006 1578 1588
34. S. Zoungas, B.P. McGrath, P. Branley, P.G. Kerr, C. Muske, and R. Wolfe Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial J Am Coll Cardiol 47 2006 1108 1116
35. R.L. Jamison, P. Hartigan, J.S. Kaufman, D.S. Goldfarb, S.R. Warren, and P.D. Guarino Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial JAMA 298 2007 1163 1170 (Pubitemid 47403102)
36. A.C. Vianna, A.J. Mocelin, T. Matsuo, D. Morais-Filho, A. Largura, and V.A. Delfino Uremic hyperhomocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events Hemodial Int 11 2007 210 216 (Pubitemid 46534555)
37. M. Ebbing, O. Bleie, P.M. Ueland, J.E. Nordrehaug, D.W. Nilsen, and S.E. Vollset Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial JAMA 300 2008 795 804
38. L. Potena, F. Grigioni, M. Masetti, G. Magnani, F. Coccolo, and F. Fallani Long-term effect of folic acid therapy in heart transplant recipients: follow-up analysis of a randomized study Transplantation 85 2008 1146 1150 (Pubitemid 351590192)
39. F. Baker, D. Picton, S. Blackwood, J. Hunt, M. Erskine, and M. Dyas Blind comparison of folic acid and placebo in patients with ischemic heart disease: an outcome trial Circulation 106 2002 A 3642
40. B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial Lancet Neurol 9 2010 855 865
41. J.M. Armitage, L. Bowman, R.J. Clarke, K. Wallendszus, R. Bulbulia, and K. Rahimi Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial JAMA 303 2010 2486 2494
42. P. Galan, E. Kesse-Guyot, S. Czernichow, S. Briancon, J. Blacher, and S. Hercberg Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial BMJ 341 2010 c6273
43. A.G. Bostom, M.A. Carpenter, J.W. Kusek, A.S. Levey, L. Hunsicker, and M.A. Pfeffer Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial Circulation 123 2011 1763 1770
44. M.S. Imasa, N.T. Gomez, and J.B. Nevado Jr. Folic acid-based intervention in non-ST elevation acute coronary syndromes Asian Cardiovasc Thorac Ann 17 2009 13 21
45. A.A. House, M. Eliasziw, D.C. Cattran, D.N. Churchill, M.J. Oliver, and A. Fine Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial JAMA 303 2010 1603 1609
46. J. Heinz, S. Kropf, U. Domrose, S. Westphal, K. Borucki, and C. Luley B vitamins and the risk of total mortality and cardiovascular disease in end-stage renal disease: results of a randomized controlled trial Circulation 121 2010 1432 1438
47. A. Hassan, B.J. Hunt, M. O'Sullivan, R. Bell, R. D'Souza, and S Jeffery Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction Brain 127 2004 212 219 (Pubitemid 38055360)
48. C. Shirodaria, C. Antoniades, J. Lee, C.E. Jackson, M.D. Robson, and J.M. Francis Global improvement of vascular function and redox state with low-dose folic acid: implications for folate therapy in patients with coronary artery disease Circulation 115 2007 2262 2270 (Pubitemid 46685894)
49. Q. Yang, L.D. Botto, J.D. Erickson, R.J. Berry, C. Sambell, and H. Johansen Improvement in stroke mortality in Canada and the United States, 1990 to 2002 Circulation 113 2006 1335 1343 (Pubitemid 43739455)
50. W. Lieb, M.G. Larson, E.J. Benjamin, X. Yin, G.H. Tofler, and J Selhub Multimarker approach to evaluate correlates of vascular stiffness: the Framingham Heart Study Circulation 119 2009 37 43
51. V. Menon, M.J. Sarnak, T. Greene, X. Wang, A.A. Pereira, and G.J. Beck Relationship between homocysteine and mortality in chronic kidney disease Circulation 113 2006 1572 1577 (Pubitemid 43739416)
52. L.G. Mikael, J. Genest Jr., and R. Rozen Elevated homocysteine reduces apolipoprotein A-I expression in hyperhomocysteinemic mice and in males with coronary artery disease Circ Res 98 2006 564 571
53. D. Liao, H. Tan, R. Hui, Z. Li, X. Jiang, J. Gaubatz, and F Yang Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I Protein synthesis and enhancing HDL cholesterol clearance Circ Res 99 2006 598 606 (Pubitemid 44401451)
54. D. Qujeq, T.S. Omran, and L. Hosini Correlation between total homocysteine, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol in the serum of patients with myocardial infarction Clin Biochem 34 2001 97 101 (Pubitemid 32322699)
55. A.G. Bostom, L.A. Cupples, J.L. Jenner, J.M. Ordovas, L.J. Seman, and P.W. Wilson Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study JAMA 276 1996 544 548 (Pubitemid 26272299)
56. S.E. Nissen, S.J. Nicholls, I. Sipahi, P. Libby, J.S. Raichlen, and C.M. Ballantyne Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial JAMA 295 2006 1556 1565